Oxford has selected major expertise vaccine manufacturing company (CIR) for further research and trial on the vaccine required for CORONA Virus

Test and trial of the vaccine required for the treatment of corona virus under process by the scientists working in the Oxford University has been declared as safe for human service as per the third exercise and trial of the clinical research .The trial of the vaccine required for the human treatment is now used for the trial on the basis of registeration for which six thousand people have registered their nominations with the Siram institute of India. The first two number trials of the vaccine have been found satisfactory.The work has been taken in hand at various places of the clinical research and reforms
The Secretary of the department has said that the Oxford has selected major manufacturing company of the expertise vaccine mark(CIR) to further work on the reforms of the required vaccine for the development of which number of informations related to the country 's  data prescription and health care check of the society and circle at different places is required to be maintained and verified for the application of the vaccine under observation and trial for the human service.